G2GBIO Overview

  • Year Founded
  • 2017

Year Founded

  • Status
  • Public

  • Employees
  • 48

Employees

  • Stock Symbol
  • 456160

Stock Symbol

  • Share Price
  • $26.15
  • (As of Friday Closing)

G2GBIO General Information

Description

G2GBIO Inc is a Biotechnology company. The company manages Drug Delivery System platform company. The company possesses microsphere source technology (InnoLAMP) for the development of sustained-release pharmaceuticals, and development a demand for extended-half-life drugs, as well as world-class mass production processes and facilities.

Contact Information

Website
www.g2gbio.com
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Corporate Office
  • 21, Uiryodanji-gil, Osong-eup
  • Heungdeok-gu
  • Cheongju, Chungcheongbuk 34054
  • South Korea
+82
Primary Industry
Drug Discovery
Stock Exchange
KRX
Vertical(s)
Manufacturing, HealthTech, Life Sciences
Corporate Office
  • 21, Uiryodanji-gil, Osong-eup
  • Heungdeok-gu
  • Cheongju, Chungcheongbuk 34054
  • South Korea
+82

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

G2GBIO Stock Performance

As of 13-Nov-2026, G2GBIO’s stock price is $26.15. Its current market cap is $435M with 16.6M shares.

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$26.15 $27.01 $15.51 - $82.48 $435M 16.6M 296K -$0.87

G2GBIO Financials Summary

As of 30-Jun-2026, G2GBIO has a trailing 12-month revenue of $1.53M.

In Thousands,
USD 		TTM 30-Jun-2026 FY 2025 31-Dec-2025 FY 2024 31-Dec-2024 FY 2023 31-Dec-2023
EV 332,037 726,420
Revenue 1,527 297 564 566
EBITDA (12,506) (7,244) (58,178)
Net Income (11,968) (8,493) (61,018)
Total Assets 152,331 47,048 17,207 24,482
Total Debt 27,160 4,949 10,753 0
Public Fundamental Data provided by Morningstar, Inc. disclaimer

G2GBIO Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore G2GBIO‘s full profile, request access.

Request a free trial

G2GBIO Patents

  • 122

    Total Documents Applications and Grants

  • Total Patents Families

  • 58

    Granted

  • 40

    Pending

  • Expiring in next 12 mo

G2GBIO Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026160925-A1 Microsphere for sustained release comprising ropivacaine Pending 23-Jan-2025
WO-2026151273-A1 Biodegradable microsphere production method with enhanced productivity and production amount Pending 08-Jan-2025
WO-2026151272-A1 Manufacturing process for biodegradable microspheres Pending 08-Jan-2025
WO-2026005556-A1 Method for preparing sustained-release microparticles containing high content of water-soluble peptide drug Pending 28-Jun-2024
WO-2026005559-A1 Method for producing large amounts of microspheres Pending 28-Jun-2024 A61K9/1647
To view G2GBIO’s complete patent history, request access »

G2GBIO Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

G2GBIO Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore G2GBIO‘s full profile, request access.

Request a free trial

G2GBIO ESG

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

Rank

Percentile

Pharmaceuticals

Industry

Rank

Percentile

Biotechnology

Subindustry

Rank

Percentile

To view G2GBIO’s complete esg history, request access »

G2GBIO FAQs

  • When was G2GBIO founded?

    G2GBIO was founded in 2017.

  • Where is G2GBIO headquartered?

    G2GBIO is headquartered in Cheongju, South Korea.

  • What is the size of G2GBIO?

    G2GBIO has 48 total employees.

  • What industry is G2GBIO in?

    G2GBIO’s primary industry is Drug Discovery.

  • Is G2GBIO a private or public company?

    G2GBIO is a Public company.

  • What is G2GBIO’s stock symbol?

    The ticker symbol for G2GBIO is 456160.

  • What is the current stock price of G2GBIO?

    As of 13-Nov-2026 the stock price of G2GBIO is $26.15.

  • What is the current market cap of G2GBIO?

    The current market capitalization of G2GBIO is $435M.

  • What is G2GBIO’s current revenue?

    The trailing twelve month revenue for G2GBIO is $1.53M.

  • What is G2GBIO’s annual earnings per share (EPS)?

    G2GBIO’s EPS for 12 months was -$0.87.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process